Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age

BACKGROUND: To determine the effectiveness of intravitreal ranibizumab (IVR) approach over 1-year follow-up in patients younger than 50 years old with central and branch retinal vein occlusion (RVO) complicated by macular edema (ME). METHODS: Prospective, open-label case series. Patients initiating...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Battaglia Parodi, Maurizio, Romano, Francesco, Arrigo, Alessandro, Mercuri, Stefano, Franceschi, Alessandro, Bandello, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320288/
https://ncbi.nlm.nih.gov/pubmed/32685489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4747696
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados